SCHEDULE OF COMMON STOCK PURCHASE WARRANTS ISSUED AND OUTSTANDING (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2021 |
Dec. 31, 2020 |
|
| Equity [Abstract] | ||
| Warrants outstanding, beginning balance | 40,764,667 | 57,043,837 |
| Weighted average eprice, beginning balance | $ 0.13 | $ 0.14 |
| Warrants outstanding, granted | 7,400,000 | 18,650,000 |
| Weighted average exercise price, granted | $ 0.09 | $ 0.15 |
| Warrants Outstanding, Exercised | (1,650.00) | |
| Weighted Average Exercise Price, Exercised | $ 0.08 | |
| Warrants outstanding, expired | (12,214,667) | (33,279,170) |
| Weighted average exercise price, expired | $ 0.11 | $ 0.19 |
| Warrants outstanding, ending balance | 35,950,000 | 40,764,667 |
| Weighted average exercise price, ending balance | $ 0.12 | $ 0.13 |
| X | ||||||||||
- Definition Weighted average exercise price, expired. No definition available.
|
| X | ||||||||||
- Definition Warrants weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, granted. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|